Clinical Study to Evaluate the Performance of Magna Ease Heart Valve in Chinese Patients
NCT ID: NCT02523066
Last Updated: 2025-05-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
215 participants
OBSERVATIONAL
2014-11-10
2025-05-07
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Trial in China for Aortic Valve Stenosis
NCT05607667
Clinical Study to Evaluate the Performance of Perimount Heart Valve in Chinese Patients
NCT02400489
Clinical Trial in China
NCT05580952
Evaluate Safety and Effectiveness of XenoSure Biological Patch in the Application of Cardiac Repair
NCT03176225
REPRISE China - Clinical Evaluation in China
NCT03084510
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Mitral Valve or Aortic Valve Replancement
One-arm group
Magna Ease
This study is non-intervention
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Magna Ease
This study is non-intervention
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The patients agree to sign the inform consent form (ICF).
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Edwards Lifesciences
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The Chinese academy of medical sciences fuwai hospital cardiovascular disease
Beijing, Beijing Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Magna Ease CN001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.